GlassScriptPhysician profile
Amy G Brenner
NPI 1366492027
$17,360.98
in general payments reported to CMS, 2019-2025
40 companies · $2,320 in 2025
The $2,320 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $644 · 2021: $2,977 · 2022: $2,714 · 2023: $4,336 · 2024: $3,641 · 2025: $2,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,836 · Food and Beverage: $3,453 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,835.50 |
| Food and Beverage | $3,452.83 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,037.67 | 2019-2025 | Botox, Liletta, Ubrelvy |
| Allergan, INC. | $5,196.57 | 2019-2023 | |
| Gynesonics, INC. | $875.67 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myriad Women'S Health, INC. | $363.94 | 2023 | Myrisk |
| Minerva Surgical, INC | $359.83 | 2019-2023 | |
| Astellas Pharma US INC | $308.26 | 2021-2025 | Veozah, Myrbetriq |
| Caldera Medical, INC | $289.39 | 2021-2024 | Desara |
| Sumitomo Pharma America, INC. | $266.96 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $257.14 | 2019-2021 | |
| Coopersurgical, INC. | $162.33 | 2020-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $147.13 | 2019-2024 | Novasure, Acessa Provu System |
| Exeltis, USA INC. | $134.99 | 2020-2024 | Slynd |
| Mayne Pharma Commercial LLC | $115.39 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $103.29 | 2021 | |
| Acella Pharmaceuticals, LLC | $82.52 | 2019-2025 | NP Thyroid 60 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $77.69 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.79 | 2019-2022 | |
| Galderma Laboratories, L.P. | $54.16 | 2024 | |
| Scynexis, INC. | $52.35 | 2022 | |
| Avion Pharmaceuticals | $51.00 | 2020-2021 | |
| Lupin INC. | $47.83 | 2019-2021 | |
| Ibsa Pharma INC. | $29.19 | 2023 | Tirosint, Licart |
| Baxter Healthcare | $28.89 | 2020 | |
| Teleflex LLC | $25.54 | 2021 | |
| Meditrina | $19.92 | 2022 | |
| Dermira, INC. | $18.72 | 2020 | |
| Pfizer INC. | $18.28 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.47 | 2022 | |
| Organon LLC | $15.26 | 2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $14.57 | 2021 | |
| Endo Pharmaceuticals INC. | $14.52 | 2020 | |
| Exact Sciences Corporation | $14.28 | 2024 | Cologuard Collection Kit |
| Millicent US INC | $13.73 | 2025 | Femlyv |
| Currax Pharmaceuticals LLC | $13.34 | 2020 | |
| Boston Scientific Corporation | $13.05 | 2019 | |
| Evofem Biosciences, INC. | $12.84 | 2021 | |
| Dysis Medical, INC. | $11.32 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.20 | 2020 | |
| Mdd US Operations, LLC | $10.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.